FDA Reviewing Data on Possible Increased Prostate Cancer Risk With Stalevo in PD
This is a discussion on FDA Reviewing Data on Possible Increased Prostate Cancer Risk With Stalevo in PD within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; The agency stresses their review is ongoing and no new conclusions or recommendations are being made at this time. Medscape ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-01-2010, 01:31 PM
|
|||
|
|||
FDA Reviewing Data on Possible Increased Prostate Cancer Risk With Stalevo in PD
The agency stresses their review is ongoing and no new conclusions or recommendations are being made at this time.
Medscape Medical News More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| AUA 2009: Dutasteride Lowers Risk for Prostate Cancer | industry_news | Other Clinical Pharmacy News | 0 | 04-28-2009 03:37 PM |
| Antidiabetic Drugs Linked to Lower Prostate Cancer Risk | industry_news | Other Clinical Pharmacy News | 0 | 11-20-2008 06:10 AM |
| Androgen-Receptor Antagonist for Advanced Prostate Cancer: 24-Week Data Available and Promising | industry_news | Other Clinical Pharmacy News | 0 | 10-24-2008 11:31 AM |
| Preliminary Data Suggest Spiriva Not Linked to Increased Stroke Risk | industry_news | Other Clinical Pharmacy News | 0 | 10-08-2008 02:50 PM |
| Radiation Added to ADT Halves Risk for Prostate Cancer Death | industry_news | Other Clinical Pharmacy News | 0 | 09-22-2008 09:16 PM |
© 2008 DrugManagementForum™ powered by |
 |